A robust antibody discovery platform is an important core factor that determines the success of a set of drug modalities. Area of antibody discovery has seen tremendous technological advancement, offerings pharma companies a wide range of tools to choose form. At Aurigene, we design our antibody discovery programs keeping therapeutic end point in mind and choose the technology platform accordingly. Our team has experience in handling several technology platforms including humanized rodent, B-cell cloning, hybridoma and display libraries.
Tool and reagent antibodies for various preclinical and clinical applications are offered. Each antibody program deliverables meets fit-for-purpose quality criteria set at the time of project initiation.
Note: Reagents like antigen/ immunogen, screening tools and isotype controls also be generated on request
Aurigene Pharmaceutical Services is
that provides contract research and manufacturing services
You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.